Font Size
-
+

Pharmacy

Latest Pharmacy News and Notices

The latest pharmacy provider billing updates and news notices will be posted here. Please check daily for updates. 

 

New Medication Management Component of Elderly & Disabled (E&D) Waiver

Exciting Opportunity for MS Medicaid Pharmacy Providers: New Medication Management Component of Elderly & Disabled (E&D) Waiver, effective 2-1-2024. Pharmacists who are interested in participating must watch the video found here and submit an email to dompharmacyoffice@medicaid.ms.gov as follows:

Email subject: “E&D Waiver medication management”
Email body: Pharmacy Name, Address and County , Pharmacist Contact Name, Phone Number, Fax Number, Medicaid ID #, NPI#

 

Flovent HFA Discontinuation on the MS Medicaid Universal Preferred Drug List (PDL)

Flovent HFA (fluticasone propionate inhalation aerosol) was recently discontinued by its manufacturer, GlaxoSmithKline. This is a business decision made by GlaxoSmithKline and not related to any new safety or efficacy information.

Background
Fluticasone propionate HFA (generic for Flovent HFA; 44, 110, & 220 mcg/act inhaled aerosol; 120 actuations with 1 canister) is indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older.

Action
Based on the discontinuation of the name brand Flovent HFA the Division of Medicaid has made the following policy changes.

1. Fluticasone HFA will remain non-preferred, however, there will be automatic approval (electronic prior authorization) of Fluticasone HFA for children aged 4- 5 years, who have a diagnosis of asthma.
2. Age waiver prior authorization submission will be required for Fluticasone HFA for children less than 4 years of age.
3. For children >6 years of age, providers should prescribe the most cost-effective drugs to the state – the preferred drugs in the Inhaled Glucocorticoid Class; Asmanex Twisthaler (mometasone), budesonide 0.25mg and 0.5mg nebulizer suspension, Pulmicort Flexhaler (budesonide), and Qvar Redihaler (beclomethasone diproprionate).

Jan. 22, 2024

 


PRN Updates for Pharmacy Providers – Updated Nov. 15, 2022

Medicaid allows the generic mandate requirement to be overridden for brand name narrow therapeutic index (NTI) drugs to include Coumadin, Dilantin, Lanoxin, Synthroid, and Tegretol … Read more.

 

Attention Pharmacy Providers! New Fiscal Agent effective October 1, 2022

The new fee-for-service (FFS) pharmacy processing information is as follows:
BIN #: 025151    PCN: DRMSPROD
Pharmacy Claims and Prior Authorization Call Center number: 1-833-660-2402
Pharmacy Prior Authorization fax number: 1-866-644-6147

Pharmacy

Claims and Prior Authorization – Gainwell Technologies

Please contact our fiscal agent, Gainwell Technologies, for questions or problems relating to any Pharmacy Prior Authorization or POS claims issues.

Toll-free: 1-833-660-2402
Pharmacy PA Fax: 1-866-644-6147
Provider/Member Call Center: 1-800-884-3222
Provider Fax: 1-866-644-6148

 

Mississippi Medicaid Prescribers – registered users
If you are a Mississippi Medicaid prescriber, submit your prior authorization requests through the Gainwell Technologies provider portal.

Medicaid Office of Pharmacy Contact Information

Phone: 601-359-5253, #4
Fax: 601-359-9555